Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
628
datasets available to search
ShareScore release 0.9.0
Dataset results
628 results for “GM”
Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00101101. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03012100. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Naxitamab and GM-CSF in Combination With IT in Patients With High-Risk Neuroblastoma
ClinicalTrials.gov study NCT04560166. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC)
ClinicalTrials.gov study NCT00488982. IPD Sharing: NO. Countries: 1. Publications: 0.
GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00521014. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GM-CSF in Treating Patients With Relapsed Prostate Cancer
ClinicalTrials.gov study NCT00908141. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF
ClinicalTrials.gov study NCT00208949. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate Cancer
ClinicalTrials.gov study NCT00400517. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic Myeloma GM-CSF Vaccine With Lenalidomide in Multiple Myeloma Patients in Complete or Near Complete Remission
ClinicalTrials.gov study NCT03376477. IPD Sharing: NO. Countries: 1. Publications: 0.
MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia
ClinicalTrials.gov study NCT00462605. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer
ClinicalTrials.gov study NCT00477087. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01542684. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healthy Subjects
ClinicalTrials.gov study NCT03306589. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete Remission
ClinicalTrials.gov study NCT01349569. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma
ClinicalTrials.gov study NCT02451488. IPD Sharing: NO. Countries: 1. Publications: 0.
Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI
ClinicalTrials.gov study NCT00363649. IPD Sharing: NO. Countries: 1. Publications: 0.
Rituximab Plus Sargramostim (GM-CSF) In Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00940342. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors
ClinicalTrials.gov study NCT01158118. IPD Sharing: NO. Countries: 1. Publications: 0.
Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00425477. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma Patients
ClinicalTrials.gov study NCT02009397. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.